School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan.
Department of Biophysics, Institute of Experimental Physics, Warsaw University, Zwirki i Wigury 93, 02 089 Warsaw, Poland.
Bioorg Med Chem. 2010 Mar 15;18(6):2275-2284. doi: 10.1016/j.bmc.2010.01.062. Epub 2010 Feb 4.
9-(5',5'-Difluoro-5'-phosphonopentyl)-9-deazaguanine (DFPP-DG) was designed as a multi-substrate analogue inhibitor against purine nucleoside phosphorylase (PNP) on the basis of X-ray crystallographic data obtained for a binary complex of 9-(5',5'-difluoro-5'-phosphonopentyl)guanine (DFPP-G) with calf-spleen PNP. DFPP-DG and its analogous compounds were synthesized by the Sonogashira coupling reaction between a 9-deaza-9-iodoguanine derivative and omega-alkynyldifluoromethylene phosphonates as a key reaction. The experimental details focused on the synthetic chemistry along with some insights into the physical and biological properties of newly synthesized DFPP-DG derivatives are disclosed.
9-(5',5'-二氟-5'-膦戊基)-9-去氮鸟嘌呤(DFPP-DG)是根据与小牛脾嘌呤核苷磷酸化酶(PNP)的二元复合物的 X 射线晶体结构数据设计的多底物类似物抑制剂,该二元复合物由 9-(5',5'-二氟-5'-膦戊基)鸟嘌呤(DFPP-G)组成。DFPP-DG 及其类似物通过 9-去氮-9-碘鸟嘌呤衍生物与 ω-炔基二氟甲叉膦酸酯之间的 Sonogashira 偶联反应作为关键反应合成。实验细节重点介绍了合成化学,并对新合成的 DFPP-DG 衍生物的物理和生物学性质进行了一些探讨。